Functional MRI of basal ganglia responsiveness to levodopa in parkinsonian rhesus monkeys
- PMID: 10448418
- DOI: 10.1006/exnr.1999.7089
Functional MRI of basal ganglia responsiveness to levodopa in parkinsonian rhesus monkeys
Abstract
Functional MRI (fMRI) was used to study striatal sensitivity to levodopa in hemiparkinsonian rhesus monkeys. Responses consistent with increased neuronal activity were seen in areas whose normal dopaminergic input from the substantia nigra pars compacta had been ablated by MPTP. Sites of increased activity following levodopa included the lateral putamen, the ventral region of the caudate head, septal areas, and midlateral amygdala in the MPTP-lesioned hemisphere. Increased activity was also observed in the same areas in the nonlesioned hemisphere, but was less pronounced in spatial extent and magnitude, suggesting either subclinical contralateral damage and/or functional adaptations in the contralateral dopamine systems. The increases in neuronal activity following levodopa treatment were temporally correlated with increases in striatal dopamine levels. Chronic levodopa treatment reduced behavioral responsiveness to levodopa and abolished the fMRI response. These results suggest that fMRI can detect changes in dopamine receptor-mediated neuronal sensitivity to dopaminergic agents.
Similar articles
-
MPTP-Induced pallidal lesions in rhesus monkeys.Exp Neurol. 1999 Jan;155(1):140-9. doi: 10.1006/exnr.1998.6976. Exp Neurol. 1999. PMID: 9918713
-
Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.Ann Neurol. 1994 Aug;36(2):206-14. doi: 10.1002/ana.410360213. Ann Neurol. 1994. PMID: 7914399
-
MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys.Ann Neurol. 1994 Jun;35(6):689-97. doi: 10.1002/ana.410350609. Ann Neurol. 1994. PMID: 8210225
-
Investigating levodopa-induced dyskinesias in the parkinsonian primate.Ann Neurol. 2000 Apr;47(4 Suppl 1):S79-89. Ann Neurol. 2000. PMID: 10762135 Review.
-
Peculiarities of L: -DOPA treatment of Parkinson's disease.Amino Acids. 2005 Mar;28(2):157-64. doi: 10.1007/s00726-005-0162-4. Epub 2005 Mar 9. Amino Acids. 2005. PMID: 15750845 Review.
Cited by
-
Improved methods for electroacupuncture and electromyographic recordings in normal and parkinsonian rhesus monkeys.J Neurosci Methods. 2010 Oct 15;192(2):199-206. doi: 10.1016/j.jneumeth.2010.07.016. Epub 2010 Jul 21. J Neurosci Methods. 2010. PMID: 20654649 Free PMC article.
-
Validations of apomorphine-induced BOLD activation correlations in hemiparkinsonian rhesus macaques.Neuroimage Clin. 2019;22:101724. doi: 10.1016/j.nicl.2019.101724. Epub 2019 Feb 18. Neuroimage Clin. 2019. PMID: 30822717 Free PMC article.
-
Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies.J Neurochem. 2011 Aug;118(3):326-38. doi: 10.1111/j.1471-4159.2011.07320.x. Epub 2011 Jun 17. J Neurochem. 2011. PMID: 21615738 Free PMC article. Review.
-
Levodopa changes brain motor network function during ankle movements in Parkinson's disease.J Neural Transm (Vienna). 2013 Mar;120(3):423-33. doi: 10.1007/s00702-012-0896-6. Epub 2012 Sep 19. J Neural Transm (Vienna). 2013. PMID: 22990677
-
Pharmacological MRI (phMRI) monitoring of treatment in hemiparkinsonian rhesus monkeys.Cell Transplant. 2008;17(4):417-25. Cell Transplant. 2008. PMID: 18522244 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous